Free Trial

Insider Selling: Afya (NASDAQ:AFYA) Insider Sells 4,161 Shares of Stock

Afya logo with Consumer Discretionary background
Image from MarketBeat Media, LLC.

Key Points

  • Afya insider Santos Welder Ferreira sold 4,161 shares at an average price of $13.30, generating $55,341.30 and reducing his position by 10.63% to 35,000 shares.
  • Afya shares rose 4.5% to $13.91, while the company reported quarterly EPS of $0.43, exceeding analyst expectations of $0.40; analysts project full-year EPS of $1.86.
  • Analyst sentiment remains mixed, with an overall “Hold” rating and an average price target of $17.75; institutional investors own approximately 88.02% of the stock.
  • MarketBeat previews top five stocks to own in November.

Afya Limited (NASDAQ:AFYA - Get Free Report) insider Santos Welder Ferreira sold 4,161 shares of Afya stock in a transaction dated Monday, October 5th. The shares were sold at an average price of $13.30, for a total value of $55,341.30. Following the completion of the transaction, the insider owned 35,000 shares of the company's stock, valued at $465,500. The trade was a 10.63% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

Afya Stock Up 4.5%

Shares of Afya stock traded up $0.60 on Tuesday, reaching $13.91. 247,503 shares of the company were exchanged, compared to its average volume of 149,659. The stock's 50 day moving average price is $13.79 and its 200-day moving average price is $14.26. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.20 and a quick ratio of 2.20. Afya Limited has a 1-year low of $11.62 and a 1-year high of $16.16. The company has a market cap of $1.30 billion, a P/E ratio of 8.48, a price-to-earnings-growth ratio of 1.37 and a beta of 0.34.

Afya (NASDAQ:AFYA - Get Free Report) last issued its earnings results on Friday, August 14th. The company reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.03. Afya had a net margin of 20.55% and a return on equity of 17.58%. The firm had revenue of $187.80 million for the quarter, compared to analysts' expectations of $189.62 million. As a group, equities analysts forecast that Afya Limited will post 1.86 EPS for the current year.

Institutional Investors Weigh In On Afya

A number of institutional investors and hedge funds have recently bought and sold shares of AFYA. Public Employees Retirement System of Ohio acquired a new position in Afya in the second quarter valued at $67,000. Engineers Gate Manager LP acquired a new stake in shares of Afya during the second quarter worth about $325,000. Finally, Banco BTG Pactual S.A. acquired a new stake in shares of Afya during the fourth quarter worth about $462,000. 88.02% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

AFYA has been the subject of a number of analyst reports. Wall Street Zen upgraded shares of Afya from a "hold" rating to a "buy" rating in a research note on Saturday, September 5th. JPMorgan Chase & Co. cut their price target on Afya from $21.50 to $21.00 and set a "neutral" rating on the stock in a research note on Monday, June 22nd. Weiss Ratings downgraded Afya from a "hold (c)" rating to a "hold (c-)" rating in a report on Friday, July 31st. Zacks Research cut Afya from a "hold" rating to a "strong sell" rating in a research report on Friday, August 21st. Finally, Bank of America reaffirmed a "neutral" rating on shares of Afya in a research report on Thursday, June 11th. One equities research analyst has rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, Afya currently has an average rating of "Hold" and an average price target of $17.75.

View Our Latest Research Report on Afya

Afya Company Profile

(Get Free Report)

Afya Limited NASDAQ: AFYA is a Brazil-based medical education and health technology company. The company provides education and professional development for physicians and other healthcare professionals, with activities spanning undergraduate medical programs, medical residency preparation, specialization courses, continuing medical education and digital learning services.

Afya also develops technology-enabled products designed to support healthcare professionals throughout their careers.

Recommended Stories

Insider Buying and Selling by Quarter for Afya (NASDAQ:AFYA)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Afya Right Now?

Before you consider Afya, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Afya wasn't on the list.

While Afya currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines